PE20090500A1 - ACYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASES - Google Patents
ACYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASESInfo
- Publication number
- PE20090500A1 PE20090500A1 PE2007001242A PE2007001242A PE20090500A1 PE 20090500 A1 PE20090500 A1 PE 20090500A1 PE 2007001242 A PE2007001242 A PE 2007001242A PE 2007001242 A PE2007001242 A PE 2007001242A PE 20090500 A1 PE20090500 A1 PE 20090500A1
- Authority
- PE
- Peru
- Prior art keywords
- hepatitis
- oximyl
- acyclic
- proteases
- aryl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000035195 Peptidases Human genes 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 Y R2 SON CADA UNO H, ARILO, HETEROARILO, ALQUILO C3-C12, ENTRE OTROS; A ES R5, (CO)OR5, (SO2)OR5, ENTRE OTROS, R5 ES ARILO, HETEROARILO, ALQUILO C1-C8, ENTRE OTROS; B ES H O CH3; L Y Z SON CADA UNO H, ARILO, HETEROCICLILO, CICLOALQUILO C1-C8, ENTRE OTROS; m Y h SON DE 0-3; n ES DE 1-3. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y COMPOSICIONES FARMACEUTICAS. DICHOS COMPUESTOS INTERFIEREN CON LA CICLO DE VIDA DEL VIRUS DE LA HEPATITIS C NS3-NS4A Y SON UTILES EN SU TRATAMIENTO, ASI COMO TAMBIEN COMO AGENTES ANTIVIRALES ADICIONALESIT REFERS TO A COMPOUND OF FORMULA I, WHERE R1 AND R2 ARE EACH H, ARYL, HETEROARYL, C3-C12 ALKYL, AMONG OTHERS; A IS R5, (CO) OR5, (SO2) OR5, AMONG OTHERS, R5 IS ARYL, HETEROARYL, C1-C8 ALKYL, AMONG OTHERS; B IS H O CH3; L AND Z ARE EACH H, ARYL, HETEROCYCLYL, C1-C8 CYCLOALKYL, AMONG OTHERS; m AND h ARE 0-3; n IS 1-3. IT ALSO REFERS TO A PHARMACEUTICAL PREPARATION AND COMPOSITION PROCEDURE. SUCH COMPOUNDS INTERFERE WITH THE LIFE CYCLE OF HEPATITIS C VIRUS NS3-NS4A AND ARE USEFUL IN ITS TREATMENT, AS WELL AS ADDITIONAL ANTIVIRAL AGENTS
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE2007001242A PE20090500A1 (en) | 2007-09-14 | 2007-09-14 | ACYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE2007001242A PE20090500A1 (en) | 2007-09-14 | 2007-09-14 | ACYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090500A1 true PE20090500A1 (en) | 2009-05-03 |
Family
ID=40951501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001242A PE20090500A1 (en) | 2007-09-14 | 2007-09-14 | ACYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASES |
Country Status (1)
| Country | Link |
|---|---|
| PE (1) | PE20090500A1 (en) |
-
2007
- 2007-09-14 PE PE2007001242A patent/PE20090500A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2515194T3 (en) | Pyrrolidine derivatives | |
| PE20121118A1 (en) | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS | |
| PE20080457A1 (en) | MACROCYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASES | |
| PE20050999A1 (en) | NOVEL KETOAMIDES WITH CYCLIC P4 AS INHIBITORS OF NS3 SERINE PROTEASE FROM HEPATITIS C VIRUS | |
| PE20130244A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| CL2011002016A1 (en) | Compounds derived from benzimidazole with inhibitory activity of the function of the ns5a protein encoded by the hepatitis c virus (vhc); pharmaceutical composition that includes them; Useful in the treatment of an infection with the hepatitis c virus (vhc). | |
| CO6361922A2 (en) | HEPATITIS C VIRUS INHIBITORS | |
| PE20080677A1 (en) | PYRROLOTRIAZINE INHIBITORS CINAZA | |
| CL2012001230A1 (en) | Compounds derived from bicycles, inhibitors of the protein ns5a; pharmaceutical composition comprising them; use in the treatment of hepatitis c. | |
| EA201171152A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| CY1111423T1 (en) | NS5B HCV Suspensions | |
| DE602008003777D1 (en) | SULFUR COMPOUNDS AS INHIBITORS OF THE NS3 SERIN PROTEASE OF HEPATITIS C VIRUS | |
| PE20141005A1 (en) | 1,3-OXAZINES AS INHIBITORS OF BACE1 AND / OR BACE2 | |
| EA200802346A1 (en) | CYCLOPROPILCONDENATED INDOBOBENZEZEPINOVA INHIBITORS OF HELPATITIS VIRUS NS5B PROTEIN | |
| PE20130647A1 (en) | INDOLES | |
| DE602007006796D1 (en) | CYCLOPROPYL-FUSED INDIGENOUS ZAZEPINE HCV NS5B HEMMER | |
| PE20142452A1 (en) | CYCLIC AMIDES AS INHIBITORS OF MetAP-2 | |
| PE20140015A1 (en) | INHIBITORS OF MACROCYCLIC PROLINE-DERIVED HCV SERINE PROTEASES | |
| PE20080072A1 (en) | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF SERINE PROTEASES | |
| PE20130279A1 (en) | NITROGENATED HETEROARYL COMPOUNDS | |
| PE20080197A1 (en) | COMBINATIONS INVOLVING THE HCV PROTEASE INHIBITOR (S), AND TREATMENT METHODS RELATED TO THE SAME (S) | |
| PE20081792A1 (en) | SERINE PROTEASE INHIBITORS | |
| EA200870164A1 (en) | TREATMENT OF VIRAL HEPATITIS | |
| PE20120207A1 (en) | DERIVATIVES OF NAPHTHALENE, AS INHIBITORS OF HCV NS5A | |
| UY29016A1 (en) | ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |